Oncotarget

Research Papers:

TNFR1 single nucleotide polymorphisms are not associated with cervical HPV-induced pre-malignant lesion but regulate in situ cervical TNFR1 expression

Natália Pereira da Rocha, Elyzabeth Avvad-Portari, Fábio Russomano, Eric Henrique Roma, Amanda Chaves Pinto, Evandro Klumb, Jacyara Macedo, Ana Teresa Gomes Fernandes and Maria da Glória Bonecini-Almeida _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2019; 10:953-965. https://doi.org/10.18632/oncotarget.26627

Metrics: PDF 202 views  |   HTML 289 views  |   ?  


Abstract

Natália Pereira da Rocha1, Elyzabeth Avvad-Portari2, Fábio Russomano3, Eric Henrique Roma1, Amanda Chaves Pinto4, Evandro Klumb5, Jacyara Macedo4, Ana Teresa Gomes Fernandes1 and Maria da Glória Bonecini-Almeida1

1Laboratory of Immunology and Immunogenetics in Infectious Diseases, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

2Department of Pathologic Anatomy, Fernandes Figueira Woman, Child and Adolescent National Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

3Women´s Health Care Area, Fernandes Figueira Woman, Child and Adolescent National Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

4Department of Biochemistry, State University of Rio de Janeiro, Rio de Janeiro, Brazil

5Department of Rheumatology, State University of Rio de Janeiro, Rio de Janeiro, Brazil

Correspondence to:

Maria da Glória Bonecini-Almeida, email: gloria.bonecini@ini.fiocruz.br

Keywords: HPV; cervical lesions; in situ TNFR1; TNFR1 SNPs

Received: August 15, 2018     Accepted: January 14, 2019     Published: January 29, 2019

ABSTRACT

TNF-α is involved in HPV infection control by triggering cell signaling through binding in specific receptors TNFR1 and TNFR2. Genetic polymorphisms in these receptors may influence TNF-α signaling. Herein, we investigated TNFR1 rs767455 and rs2234649 single nucleotide polymorphisms, and TNFR1 protein expression in cervical squamous intraepithelial lesions (SIL) to identify their role in cervical pre-malignant development. SIL patients (n = 179) and healthy volunteers (n = 227) were enrolled for TNFR1 genotyping analysis by PCR-RFLP in blood samples and TNFR1 protein expression in cervical tissue by immunohistochemistry. No statistical differences regard genotypes and allelic frequencies for both polymorphisms were observed. Cervical TNFR1-expressing cells were rare in epithelium and basal layer regardless the groups. However, a progressive increase in infiltrating cells was observed in the stromal area, mainly in high SIL (HSIL) group compared to low SIL (LSIL, p < 0.001) and control (p < 0.001) groups. TNFR1-expressing cells frequency was higher in TNFR1 rs767455AG/GG (p < 0.001), and in rs2234649AA (p < 0.001) genotypes carries in HSIL subgroup. These data indicated that TNFR1-expression is abrogated in cervical epithelium, where HPV-induced pre-malignant lesion occurs, increasing its frequency in inflammatory cells in stroma, and is genetically controlled by TNFR1 rs767455AG/GG and rs234649AA genotypes. These biomarkers may be useful to identify cervical precancerous lesions progression.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26627